CPAP APAP denied for missing prior authorization by UnitedHealthcare?
If the original prescription wasn't run through prior auth, the path is to submit a PA now with a medical-necessity letter — many plans then back-date approval to the date of service.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What UnitedHealthcare typically requires
UnitedHealthcare's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The UnitedHealthcare angle on CPAP APAP
## Why UnitedHealthcare Denied Your CPAP/APAP for "Prior Authorization Required" — and How to Appeal
UHC requires prior authorization (PA) for CPAP and APAP as durable medical equipment before the device is dispensed. A PA-required denial means either the device was provided without an approved PA on file, the PA was requested but denied for failure to meet documentation requirements, or the PA was not submitted through the correct channel. This is one of the most common DME denial types — and also one of the most reversible.
## Why This Denial Is Appealable
A procedural PA failure does not mean the device was not medically necessary. The appeal must demonstrate two things: (1) all of UHC's coverage criteria for CPAP/APAP were met at the time of service; and (2) if a PA was never submitted, there is a valid basis for retroactive authorization (typically, the prescribing physician confirms the medical necessity as of the date of service). Where a PA was submitted and denied, the appeal is a substantive medical-necessity review.
## Federal Appeal Framework
- ERISA §503: Full-and-fair internal review; the reviewer must have relevant clinical expertise and must not have been involved in the original denial. You are entitled to the criteria used and to submit a response addressing each.
- ACA §2719 / External Review: After exhausting internal appeals, request IRO review within approximately four months of the final internal denial. The exact deadline is on the denial letter.
- Expedited review: If you have a current, urgent clinical need and delay would cause harm, document it explicitly and request the expedited (72-hour) track.
## Concrete Appeal Steps and Timeline
1. Determine whether the denial is for a missing PA or a denied PA — the path forward differs. - Missing PA: Ask your prescriber to submit a PA request immediately and simultaneously file a retroactive-authorization appeal. - Denied PA: Proceed directly with an appeal of the PA denial, addressing the specific clinical criteria UHC cited. 2. Obtain UHC's current CPAP/APAP PA criteria from the UHC Provider Portal (uhcprovider.com) or by calling the DME authorization line. 3. Submit the Level 1 internal appeal within the deadline on the denial letter (commonly 180 days from date of denial). 4. If denied at Level 1, escalate to Level 2 internal appeal (if available) and then to external IRO review within four months.
## Documentation to Gather
- Sleep study report: The full polysomnogram or home sleep apnea test, signed by a qualified interpreting provider, clearly showing the OSA diagnosis at the severity level UHC's policy requires.
- Prescriber order: A written, dated order from a licensed provider specifying CPAP or APAP and the clinical indication, predating or contemporaneous with the device dispensing date.
- PA submission records: Any authorization reference numbers, portal submissions, or fax confirmations showing the PA was attempted — or an explanation of why it was not.
- Medical-necessity letter: A detailed letter from the prescribing physician stating the diagnosis, clinical severity, treatment rationale, and confirmation that all UHC criteria were met as of the service date.
- Compliance plan: If the device has already been in use, a CPAP compliance download showing active, regular use — this strengthens both retroactive and prospective authorization requests.
## Criteria-Mapping Structure
Download the current UHC CPAP/APAP PA criteria. Create a table with each criterion in the left column. In the right column, cite the specific document and exhibit in your appeal packet that satisfies each criterion. Close with a paragraph from the prescriber confirming that all criteria were met on the date of service and that any PA failure was procedural, not clinical.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- UnitedHealthcare denied for missing prior authorization of ABA Autism
- UnitedHealthcare denied for missing prior authorization of Amphetamine Stimulant
- UnitedHealthcare denied for missing prior authorization of Amphetamine Stimulant Prodrug
- UnitedHealthcare denied for missing prior authorization of Anti Amyloid Leqembi